June 2009 Volume 5, Issue 6

Volume 5, Issue 6 | June 2009

June 2009

In this Issue

Research & Development

Drug Discovery News Placeholder Image

J&J pounces on Cougar

Johnson & Johnson to acquire oncology drug developer Cougar Biotechnology for $1 billion
Drug Discovery News Placeholder Image

Pfizer takes lead role in stem cell research

Agreements with University College London, U of Wisconsin—Madison part of $100 million investment in international stem cell development program
Drug Discovery News Placeholder Image

Sanofi-aventis to acquire BiPar Sciences in a deal worth up to $500 million

Acquisition expected to add to oncology portfolio, late-stage drug programs
Drug Discovery News Placeholder Image

Merck, Medarex and MBL enter antibody deal

Worldwide licensing agreement will target C. difficile infection
Drug Discovery News Placeholder Image

Companies to apply proprietary analytical technique to Alzheimer’s disease research

Back-scattering interferometry offers promise of revolutionizing screening for drugs that inhibit amyloid build-up
Drug Discovery News Placeholder Image

Utah researchers collaborate on stem cell therapy for ALS

A team of Utah-based researchers are collaborating on a stem cell therapy to fight amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.
Drug Discovery News Placeholder Image

Catalyst to ‘industrialize’ stem cell tech

Fate Therapeutics and Stemgent establish consortium to offer stem cell advances to the research market

Informatics

Drug Discovery News Placeholder Image

Dealing with a deluge of data

NextBio announces informatics licensing agreement with Merck
Drug Discovery News Placeholder Image

Analyzing data at single-cell level

PerkinElmer and Accelrys announce software collaboration to enable single-cell imaging using high-content screening technology
Drug Discovery News Placeholder Image

Clinical trial traceability

Phase Forward acquires Waban Software to create integrated data analysis and reporting solution
Drug Discovery News Placeholder Image

Heads in the clouds

Applied Bio and Geospiza team up to offer next-gen genetic analysis via Amazon Web Services
Drug Discovery News Placeholder Image

Taking a shine to Golden Helix

Agilent partners up with genetic analysis expert to create tool for wider-scale adoption of large CNV association studies

Automation & Instrumentation

Drug Discovery News Placeholder Image

PerkinElmer acquires Analytica of Branford

Investment intended to enhance mass spec portfolio and expertise
Drug Discovery News Placeholder Image

Partners in pathway lucidation

Marketing agreement between Roche NimbleGen and Sigma-Aldrich seeks to ease epigenetic research bottlenecks
Drug Discovery News Placeholder Image

Breaking into the market

Co-marketing deal gives Agilent a good opening to enter the next-gen sequencing market and gives Illumina customers a new and necessary tool
Drug Discovery News Placeholder Image

Fighting the flu

Millipore and Microbix to co-develop novel purification process in influenza vaccine manufacturing
Drug Discovery News Placeholder Image

Bringing the biomarkers together

BD and Fujirebio Diagnostics to jointly develop biomarker assays for early ovarian cancer detection
Drug Discovery News Placeholder Image

Responding to the market

Cellectricon and BioFocus team up to advance high-throughput ion channel drug discovery

Global News

Drug Discovery News Placeholder Image

Bayer, Ardea MEK-ing progress

Bayer and Ardea enter global agreement focused on the development of MEK inhibitors for the treatment of cancer
Drug Discovery News Placeholder Image

Risks and rewards

AstraZeneca signs R&D deal worth up to $220 million with India’s Jubilant
Drug Discovery News Placeholder Image

South Pacific acquisition

Thermo Fisher Scientific pens $120M deal to acquire Biolab, a life science tools provider in New Zealand and Australia
Drug Discovery News Placeholder Image

Evotec catches Zebrafish

Acquisition of Summit’s Zebrafish unit will expand geographic reach to Asia
Drug Discovery News Placeholder Image

‘Made in China’ gains new meaning

Abbott to select from 600 Chinese drug and biomarker compounds via HUYA Bioscience

Editor's Focus

Drug Discovery News Placeholder Image

Media’s treatment of Big Pharma can sometimes be a bitter pill to swallow

Last month, many major news groups elected to take what should have been perceived as good news in a bad economy, and presented it as yet another slam on greedy, bloodsucking Big Pharma. Is it any wonder that most Americans express dissatisfaction with our healthcare system?

Patent News

Drug Discovery News Placeholder Image

ACLU mob attacks breast cancer test patent

The fight over the patentability of isolated genes is misplaced since patents are usually obtained not just for the isolated gene, but also for methods of use and as part of more complex assays or kits.

Commentary

Drug Discovery News Placeholder Image

How small CROs can survive and thrive in a shaky economy

In a shaky economy where demand from sponsor companies is slack, small CROs may want to consider various partnership strategies to improve stability and profitability—or be forced to liquidate. Examining current industry, economic and political trends will help CROs determine the best strategy and even thrive in the months ahead.

Genomics & Proteomics

Drug Discovery News Placeholder Image

Twice is quite nice

Isis and Alnylam extend their existing collaboration to develop single-stranded RNAi technology
Drug Discovery News Placeholder Image

Buying local

TheraCode acquires fellow German company JPT Peptide Technologies
Drug Discovery News Placeholder Image

Researchers unlock autism puzzle piece

Largest study of autism finds genes linked to brain cell connections
Drug Discovery News Placeholder Image

That two may become one

MDS Pharma’s OncoPanel combined with Compendia’s Oncomine to help speed development of cancer drugs
Drug Discovery News Placeholder Image

Continuing down the right pathway

Clinical Data continues to push FCGR work with monoclonal antibodies forward, adding two new research partners to explore this pathway
Drug Discovery News Placeholder Image

Serving it up rare

RainDance Technologies and Expression Analysis pair up on resequencing solutions looking at rare gene variants in cancer populations
Drug Discovery News Placeholder Image

Multiplex choice

Study probing how healthy younger adults make use of genetic tests
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue